← Open Payments lookup

TITI OMOYAJOWO: Open Payments

NPI 1215686738 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$539 in 21 payments from 8 companies in 2025. Trend: 2023 $546 · 2024 $763 · 2025 $539

Food & beverage: $530Education: $10
CompanyPaymentsAmount
ABBVIE INC.9$163
Alkermes, Inc.2$155
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)4$94
Otsuka America Pharmaceutical, Inc.2$36
Sage Therapeutics, LLC1$25
Supernus Pharmaceuticals, Inc.1$25
Axsome Therapeutics, Inc.1$25
Teva Pharmaceuticals USA, Inc.1$17

Products named: VRAYLAR, ARISTADA, CAPLYTA, ZURZUVAE, Qelbree, Auvelity, ABILIFY ASIMTUFII, UZEDY.

Industry payments across TX — which companies pay providers there.